Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Sherif A Maher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, New Valley University, El-kharga City, Egypt. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Plant Extracts. Die Arbeit nennt 84 Literaturangaben. Gefördert von: The authors received no specific funding for this study..
Abstract (Originalsprache)
The antidiabetic efficacy of Elaeocarpus grandis , belonging to the Family Elaeocarpaceae, was investigated using the streptozotocin‐induced hyperglycemia model. The ethyl acetate and petroleum ether fractions demonstrated a notable hypoglycemic impact in a rat model of type 2 diabetes mellitus (T2DM), compared to the negative control group. The chemical assessment of these fractions resulted in the isolation and identification of six known compounds ( 17–22 ). LC‐HR‐ESI‐MS metabolomic profiling yielded the provisional identification of sixteen metabolites ( 1–16 ) across various chemical classes. In silico investigations, encompassing molecular docking and dynamics simulations, indicated that the compounds heterophylliin A ( 22 ), as well as habbemine A ( 12 ) and elaeocarpinoside ( 15 ), can interact with critical enzymes implicated in glucose metabolism, specifically dipeptidyl peptidase‐IV and aldose reductase. Moreover, heterophylliin A ( 22 ) markedly decreased the expression of inflammatory markers ( IL‐1β, TNF‐α, IL‐6 , and TGF‐β ) in diabetic rats. These findings prompt additional research on E. grandis , specifically its bioactive constituent heterophylliin A, which exhibits intriguing antidiabetic effects and warrants further exploration as a potential treatment agent for T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, New Valley University, El-kharga City, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, New Valley University, El-kharga City, Egypt.
- IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Deraya University, Minia, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Port Said University, Port Said, Egypt.
- Department of Pharmacognosy, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt.
ORCID-Profile: Usama Ramadan Abdelmohsen
Förderung
- The authors received no specific funding for this study.
Zitieren
APA
Maher, S. A., El-Dien, R. T. M., Mustafa, M., Khedr, A. I. M., Sayed, A. M., Abdelmohsen, U. R., Fouad, M. A., & Kamel, M. S. (2025). Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70110
Vancouver
Maher SA, El-Dien RTM, Mustafa M, Khedr AIM, Sayed AM, Abdelmohsen UR, et al. Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70110
BibTeX
@article{Maher2025,
author = {Maher, Sherif A and El-Dien, Radwa Taher Mohie and Mustafa, Muhamad and Khedr, Amgad I M and Sayed, Ahmed M and Abdelmohsen, Usama Ramadan and Fouad, Mostafa A and Kamel, Mohamed Salah},
title = {Exploring the Antidiabetic Potential of Heterophylliin A From Elaeocarpus grandis},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70110}
}
EUVIMED